Thierry Le Chevalier

23.0k total citations · 7 hit papers
244 papers, 15.5k citations indexed

About

Thierry Le Chevalier is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Thierry Le Chevalier has authored 244 papers receiving a total of 15.5k indexed citations (citations by other indexed papers that have themselves been cited), including 180 papers in Pulmonary and Respiratory Medicine, 145 papers in Oncology and 38 papers in Molecular Biology. Recurrent topics in Thierry Le Chevalier's work include Lung Cancer Treatments and Mutations (155 papers), Lung Cancer Research Studies (97 papers) and Lung Cancer Diagnosis and Treatment (77 papers). Thierry Le Chevalier is often cited by papers focused on Lung Cancer Treatments and Mutations (155 papers), Lung Cancer Research Studies (97 papers) and Lung Cancer Diagnosis and Treatment (77 papers). Thierry Le Chevalier collaborates with scholars based in France, United States and United Kingdom. Thierry Le Chevalier's co-authors include Jean‐Pierre Pignon, R. Arriagada, Jean‐Charles Soria, Frances A. Shepherd, Ariane Dunant, Fabrice André, Jean‐Yves Douillard, Michèle Tarayre, Robert Pirker and Lesley Seymour and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Thierry Le Chevalier

241 papers receiving 15.0k citations

Hit Papers

Lung Adjuvant Cisplatin Evaluation: A Pooled... 1991 2026 2002 2014 2008 2006 2002 1994 1991 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
    2008 1.8k citations Jean‐Pierre Pignon, Hélène Tribodet et al. Journal of Clinical Oncology profile →
  2. DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy
    2006 1.3k citations Ariane Dunant, Élisabeth Brambilla et al. profile →
  3. Malignant effusions and immunogenic tumour-derived exosomes
    2002 793 citations Fabrice André, Thierry Le Chevalier et al. profile →
  4. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
    1994 677 citations Thierry Le Chevalier, Jean‐Yves Douillard et al. Journal of Clinical Oncology profile →
  5. Radiotherapy Alone Versus Combined Chemotherapy and Radiotherapy in Nonresectable Non-Small-Cell Lung Cancer: First Analysis of a Randomized Trial in 353 Patients
    1991 623 citations Thierry Le Chevalier, R. Arriagada et al. profile →
  6. Non-small-cell lung cancer
    2011 584 citations Thierry Le Chevalier, Frances A. Shepherd et al. profile →
  7. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
    2010 444 citations R. Arriagada, Thierry Le Chevalier et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thierry Le Chevalier France 57 10.0k 8.2k 3.6k 2.3k 1.4k 244 15.5k
Beow Y. Yeap United States 68 10.3k 1.0× 7.1k 0.9× 3.1k 0.9× 2.2k 0.9× 1.3k 1.0× 206 14.4k
Keyue Ding Canada 45 8.4k 0.8× 8.1k 1.0× 3.4k 0.9× 2.6k 1.1× 1.7k 1.2× 218 14.5k
George R. Blumenschein United States 60 5.1k 0.5× 7.0k 0.9× 2.7k 0.8× 2.4k 1.1× 1.2k 0.9× 328 12.0k
Keith M. Kerr United Kingdom 55 11.3k 1.1× 9.7k 1.2× 3.4k 0.9× 3.4k 1.5× 1.4k 1.0× 187 17.6k
J. Wanders Netherlands 38 7.9k 0.8× 11.1k 1.4× 4.2k 1.2× 2.8k 1.2× 3.0k 2.2× 132 19.6k
Danny Rischin Australia 56 6.2k 0.6× 7.8k 0.9× 3.1k 0.9× 2.2k 0.9× 3.0k 2.2× 369 15.4k
Mark A. Socinski United States 69 14.6k 1.5× 15.1k 1.8× 4.9k 1.4× 3.0k 1.3× 1.2k 0.9× 518 22.3k
Heather A. Wakelee United States 60 7.5k 0.7× 6.9k 0.8× 3.9k 1.1× 4.0k 1.7× 852 0.6× 447 13.5k
Masahiro Fukuoka Japan 55 16.7k 1.7× 15.2k 1.9× 6.1k 1.7× 3.3k 1.4× 1.2k 0.9× 266 22.5k
Johan Vansteenkiste Belgium 41 13.2k 1.3× 12.9k 1.6× 4.4k 1.2× 2.9k 1.2× 1.1k 0.8× 169 18.6k

Countries citing papers authored by Thierry Le Chevalier

Since Specialization
Citations

This map shows the geographic impact of Thierry Le Chevalier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Le Chevalier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Le Chevalier more than expected).

Fields of papers citing papers by Thierry Le Chevalier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Le Chevalier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Le Chevalier. The network helps show where Thierry Le Chevalier may publish in the future.

Co-authorship network of co-authors of Thierry Le Chevalier

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Le Chevalier. A scholar is included among the top collaborators of Thierry Le Chevalier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Le Chevalier. Thierry Le Chevalier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Collaud, Stéphane, Benjamin Besse, Dominique Fabre, et al.. (2018). Should surgery be part of the multimodality treatment for stage IIIB non‐small cell lung cancer?. Journal of Surgical Oncology. 117(7). 1570–1574. 5 indexed citations
2.
Ma, Xiaoli, Gwénaël Le Teuff, Benjamin Lacas, et al.. (2016). Prognostic and Predictive Effect of TP53 Mutations in Patients with Non–Small Cell Lung Cancer from Adjuvant Cisplatin–Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis. Journal of Thoracic Oncology. 11(6). 850–861. 77 indexed citations
3.
Rotolo, Federico, Ariane Dunant, Thierry Le Chevalier, Jean‐Pierre Pignon, & R. Arriagada. (2014). Adjuvant cisplatin-based chemotherapy in nonsmall-cell lung cancer: new insights into the effect on failure type via a multistate approach. Annals of Oncology. 25(11). 2162–2166. 24 indexed citations
4.
Mercier, Olaf, Sacha Mussot, Dominique Fabre, et al.. (2014). Is sacrifying the phrenic nerve during thymoma resection worthwhile?. European Journal of Cardio-Thoracic Surgery. 45(5). e151–e155. 17 indexed citations
5.
Mercier, Olaf, Élie Fadel, Maria‐Rosa Ghigna, et al.. (2012). Solitary Fibrous Tumor of the Pleura: Outcomes of 157 Complete Resections in a Single Center. The Annals of Thoracic Surgery. 94(2). 394–400. 70 indexed citations
6.
Chevalier, Thierry Le. (2010). Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?. Annals of Oncology. 21. vii196–vii198. 93 indexed citations
7.
Früh, Martin, Estelle Rolland, Jean‐Pierre Pignon, et al.. (2008). Pooled Analysis of the Effect of Age on Adjuvant Cisplatin-Based Chemotherapy for Completely Resected Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 26(21). 3573–3581. 132 indexed citations
8.
Filipits, Martin, Vincent Haddad, Katharina Schmid, et al.. (2007). Multidrug Resistance Proteins Do Not Predict Benefit of Adjuvant Chemotherapy in Patients with Completely Resected Non–Small Cell Lung Cancer: International Adjuvant Lung Cancer Trial Biologic Program. Clinical Cancer Research. 13(13). 3892–3898. 66 indexed citations
9.
Besse, Benjamin, Thierry Le Chevalier, & Jean‐Charles Soria. (2004). Prédiction de la réponse à l’Iressa® : un mécanisme inattendu. médecine/sciences. 20. 750–751. 1 indexed citations
10.
Chevalier, Thierry Le, et al.. (2004). Inhibiteurs de la cyclo-oxygénase 2 et chimioprévention des cancers. Bulletin du Cancer. 91(1). 77–84. 3 indexed citations
11.
Gridelli, Cesare, Andrea Ardizzoni, Thierry Le Chevalier, et al.. (2004). Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel. Annals of Oncology. 15(3). 419–426. 121 indexed citations
12.
Sabatier, Laure, et al.. (2003). Thérapeutiques moléculaires ciblées en cancérologie bronchique. Bulletin du Cancer. 90(12). 1055–1061. 1 indexed citations
13.
Arriagada, R., M. Spielmann, Serge Koscielny, et al.. (2002). Patterns of failure in a randomized trial of adjuvant chemotherapy in postmenopausal patients with early breast cancer treated with tamoxifen. Annals of Oncology. 13(9). 1378–1386. 17 indexed citations
14.
Mattson, K., Lionel Bosquée, G Dabouis, et al.. (2000). Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice. Lung Cancer. 29(3). 205–216. 19 indexed citations
15.
Grunenwald, Dominique, Lorenzo Spaggiari, Philippe Girard, et al.. (1997). Résection pulmonaire pour récidive métastatique aprèspneumonectomie pour métastases. Bulletin du Cancer. 84(3). 1 indexed citations
16.
Chevalier, Thierry Le, Maya Gottfried, U. Gatzemeier, et al.. (1997). Etude multicentrique de phase II de la gemcitabine dans les cancers bronchiques non à petites cellules (CBNPC). Bulletin du Cancer. 84(3). 282–288. 1 indexed citations
17.
Grunenwald, Dominique, Lorenzo Spaggiari, Philippe Girard, et al.. (1997). Lung resection for recurrence after pneumonectomy for metastases.. PubMed. 84(3). 277–81. 10 indexed citations
18.
Chevalier, Thierry Le. (1996). Single-agent activity of gemcitabine in advanced non-small cell lung cancer.. PubMed. 23(5 Suppl 10). 36–42. 20 indexed citations
19.
20.
Arriagada, R., B. Pellae-Cosset, F Benna, et al.. (1991). Alternating radiotherapy and chemotherapy schedules in limited small cell lung cancer: analysis of local chest recurrences. Radiotherapy and Oncology. 20(2). 91–98. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beow Y. Yeap Breakdown of academic impact, for papers by Keyue Ding Breakdown of academic impact, for papers by George R. Blumenschein Breakdown of academic impact, for papers by Keith M. Kerr Breakdown of academic impact, for papers by J. Wanders Breakdown of academic impact, for papers by Danny Rischin Breakdown of academic impact, for papers by Mark A. Socinski Breakdown of academic impact, for papers by Heather A. Wakelee Breakdown of academic impact, for papers by Masahiro Fukuoka Breakdown of academic impact, for papers by Johan Vansteenkiste
Rankless by CCL
2026